These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24904280)

  • 1. Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury.
    Wilson SM; Ki Yeon S; Yang XF; Park KD; Khanna R
    Front Cell Neurosci; 2014; 8():135. PubMed ID: 24904280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
    Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
    Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth.
    Wilson SM; Moutal A; Melemedjian OK; Wang Y; Ju W; François-Moutal L; Khanna M; Khanna R
    Front Cell Neurosci; 2014; 8():196. PubMed ID: 25104922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization.
    Wilson SM; Xiong W; Wang Y; Ping X; Head JD; Brittain JM; Gagare PD; Ramachandran PV; Jin X; Khanna R
    Neuroscience; 2012 May; 210():451-66. PubMed ID: 22433297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide.
    Wilson SM; Khanna R
    Mol Neurobiol; 2015 Apr; 51(2):599-609. PubMed ID: 24944082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.
    Yu J; Moutal A; Dorame A; Bellampalli SS; Chefdeville A; Kanazawa I; Pham NYN; Park KD; Weimer JM; Khanna R
    Mol Neurobiol; 2019 Jul; 56(7):5241-5255. PubMed ID: 30565051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation.
    Moutal A; Villa LS; Yeon SK; Householder KT; Park KD; Sirianni RW; Khanna R
    Mol Neurobiol; 2018 May; 55(5):4403-4416. PubMed ID: 28660485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide modulates collapsin response mediator protein 2 and inhibits mossy fiber sprouting after kainic acid-induced status epilepticus.
    Wang X; Yu Y; Ma R; Shao N; Meng H
    Neuroreport; 2018 Nov; 29(16):1384-1390. PubMed ID: 30169428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain.
    Moutal A; Luo S; Largent-Milnes TM; Vanderah TW; Khanna R
    Neurobiol Pain; 2019; 5():. PubMed ID: 31080913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. aFGF Promotes Neurite Growth by Regulating GSK3β-CRMP2 Signaling Pathway in Cortical Neurons Damaged by Amyloid-β.
    Cao Q; Meng T; Man J; Peng D; Chen H; Xiang Q; Su Z; Zhang Q; Huang Y
    J Alzheimers Dis; 2019; 72(1):97-109. PubMed ID: 31561361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo.
    Cole AR; Causeret F; Yadirgi G; Hastie CJ; McLauchlan H; McManus EJ; Hernández F; Eickholt BJ; Nikolic M; Sutherland C
    J Biol Chem; 2006 Jun; 281(24):16591-8. PubMed ID: 16611631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation.
    Cole AR; Soutar MP; Rembutsu M; van Aalten L; Hastie CJ; McLauchlan H; Peggie M; Balastik M; Lu KP; Sutherland C
    J Biol Chem; 2008 Jun; 283(26):18227-37. PubMed ID: 18460467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc Deficiency Decreases Neurite Extension via CRMP2 Signal Pathway.
    Kurita H; Ueda M; Kimura M; Okuda A; Ohuchi K; Hozumi I; Inden M
    Biol Pharm Bull; 2024; 47(4):796-800. PubMed ID: 38583951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.
    Nagai J; Owada K; Kitamura Y; Goshima Y; Ohshima T
    Exp Neurol; 2016 Mar; 277():283-295. PubMed ID: 26795088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of CRMP2 by Cdk5 and GSK-3β participates in sevoflurane-induced dendritic development abnormalities and cognitive dysfunction in developing rats.
    Liao Z; Huang Z; Li J; Li H; Miao L; Liu Y; Zhang J; Xu Y; Li Y
    Toxicol Lett; 2021 May; 341():68-79. PubMed ID: 33548343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.
    Hensley K; Venkova K; Christov A; Gunning W; Park J
    Mol Neurobiol; 2011 Jun; 43(3):180-91. PubMed ID: 21271304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
    Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice.
    Nakamura H; Takahashi-Jitsuki A; Makihara H; Asano T; Kimura Y; Nakabayashi J; Yamashita N; Kawamoto Y; Nakamura F; Ohshima T; Hirano H; Tanaka F; Goshima Y
    Neurochem Int; 2018 Oct; 119():207-217. PubMed ID: 29758318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.